Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-27

Clinical Trial Update: A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and Dyslipidemia

View source ↗

Summary

This clinical trial update reports a combination drug consisting of fimasartan and a statin studied in hypertension with dyslipidemia; the trial status is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fimasartan + statin (fimasartan and statin)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Hypertension and Dyslipidemia | Status: COMPLETED